Skip to main content
On target dosing: erythropoietin exposure in neonates with hypoxic-ischemic encephalopathy in the HEAL trial.
Desmopressin dosing in children using real-world data and pharmacokinetic/pharmacodynamic model simulations.
Mild HIE and therapeutic hypothermia: gaps in knowledge with under-powered trials.
Resuscitation arterial waveform quantification and outcomes in pediatric bidirectional Glenn and Fontan patients.
Biomarker screening for pulmonary hypertension in VLBW infants at risk for bronchopulmonary dysplasia.
Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment.
Perinatal arterial ischemic stroke diagnosed in infants receiving therapeutic hypothermia for hypoxic-ischemic encephalopathy.
Bilirubinemia and retinopathy of prematurity in infants ≤ 29 weeks' gestational age.
Polygenic risk for obesity and body dissatisfaction: beyond BMI.
Neonatal cardiopulmonary resuscitation: is ROSC enough?